These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17510433)

  • 1. Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process.
    Preynat-Seauve O; Contassot E; Schuler P; Piguet V; French LE; Huard B
    Cancer Res; 2007 May; 67(10):5009-16. PubMed ID: 17510433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.
    Cuenca A; Cheng F; Wang H; Brayer J; Horna P; Gu L; Bien H; Borrello IM; Levitsky HI; Sotomayor EM
    Cancer Res; 2003 Dec; 63(24):9007-15. PubMed ID: 14695219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen.
    Bai XF; Gao JX; Liu J; Wen J; Zheng P; Liu Y
    Cancer Res; 2001 Sep; 61(18):6860-7. PubMed ID: 11559562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction.
    Contassot E; Preynat-Seauve O; French L; Huard B
    Trends Immunol; 2009 Dec; 30(12):569-73. PubMed ID: 19837632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
    Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
    Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
    Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
    Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.
    Müller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K
    Cancer Res; 1998 Dec; 58(23):5439-46. PubMed ID: 9850077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.
    Carrière V; Colisson R; Jiguet-Jiglaire C; Bellard E; Bouche G; Al Saati T; Amalric F; Girard JP; M'Rini C
    Cancer Res; 2005 Dec; 65(24):11639-48. PubMed ID: 16357175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigens are constitutively presented in the draining lymph nodes.
    Marzo AL; Lake RA; Lo D; Sherman L; McWilliam A; Nelson D; Robinson BW; Scott B
    J Immunol; 1999 May; 162(10):5838-45. PubMed ID: 10229818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
    Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
    Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
    J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease.
    Avogadri F; Mittal D; Saccheri F; Sarrafiore M; Ciocca M; Larghi P; Orecchia R; Rescigno M
    Eur J Immunol; 2008 Jul; 38(7):1937-47. PubMed ID: 18581324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
    Sheng KC; Kalkanidis M; Pouniotis DS; Esparon S; Tang CK; Apostolopoulos V; Pietersz GA
    Eur J Immunol; 2008 Feb; 38(2):424-36. PubMed ID: 18200633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.
    Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D
    Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.